Pediatric Ulcerative Colitis Clinical Trial
Official title:
Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of TA-650 in Pediatric Patients With Moderate to Severe Ulcerative Colitis.
The purpose of this study is to evaluate the the efficacy of TA-650 using Clinical activity index (CAI) score and other evaluation indicators in pediatric patients with moderate to severe ulcerative colitis after TA-650 administration of at a dose of 5 mg/kg at weeks 0, 2, and 6, and then every 8 weeks at weeks 14 and 22. The safety and pharmacokinetics are also evaluated.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT04348890 -
Proof of Concept Trial of Vamorolone in Pediatric Ulcerative Colitis
|
Phase 1/Phase 2 | |
Recruiting |
NCT05673278 -
Non-Invasive Monitoring Through Bowel Ultrasound in Paediatric Inflammatory Bowel Disease Study
|
||
Completed |
NCT05591976 -
Exercise Training in Youth With Inflammatory Bowel Disease
|
N/A | |
Terminated |
NCT03827109 -
Peer Mentoring to Improve Self-management in Youth With IBD
|
N/A | |
Terminated |
NCT02694042 -
Mission is Remission®: How Can a Disease Self-management Website Change Care?
|
N/A |